Veru Inc (VERU)
1.215
-0.10
(-7.95%)
USD |
NASDAQ |
Apr 25, 16:00
1.23
+0.02
(+1.23%)
After-Hours: 20:00
Veru Price: 1.215 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 1.30 | 1.38 | 1.28 | 1.32 | 1.529M |
| Apr 23, 2024 | 1.29 | 1.48 | 1.27 | 1.275 | 2.636M |
| Apr 22, 2024 | 1.35 | 1.355 | 1.25 | 1.27 | 1.410M |
| Apr 19, 2024 | 1.39 | 1.55 | 1.30 | 1.31 | 2.614M |
| Apr 18, 2024 | 1.14 | 1.425 | 1.00 | 1.42 | 7.020M |
| Apr 17, 2024 | 1.25 | 1.28 | 1.125 | 1.16 | 2.515M |
| Apr 16, 2024 | 1.42 | 1.44 | 1.24 | 1.255 | 3.203M |
| Apr 15, 2024 | 1.51 | 1.53 | 1.11 | 1.53 | 7.168M |
| Apr 12, 2024 | 1.81 | 1.85 | 1.41 | 1.52 | 6.387M |
| Apr 11, 2024 | 1.27 | 1.92 | 1.26 | 1.79 | 17.82M |
| Apr 10, 2024 | 1.14 | 1.24 | 1.05 | 1.24 | 2.465M |
| Apr 09, 2024 | 1.06 | 1.25 | 1.04 | 1.17 | 6.190M |
| Apr 08, 2024 | 0.95 | 1.09 | 0.90 | 1.03 | 3.374M |
| Apr 05, 2024 | 0.83 | 0.93 | 0.8299 | 0.9251 | 2.449M |
| Apr 04, 2024 | 0.8224 | 0.8799 | 0.80 | 0.83 | 1.534M |
| Apr 03, 2024 | 0.7847 | 0.85 | 0.775 | 0.829 | 2.946M |
| Apr 02, 2024 | 0.759 | 0.78 | 0.6999 | 0.7742 | 1.097M |
| Apr 01, 2024 | 0.7168 | 0.77 | 0.67 | 0.76 | 2.281M |
| Mar 28, 2024 | 0.69 | 0.7697 | 0.69 | 0.7001 | 5.929M |
| Mar 27, 2024 | 0.6096 | 0.6467 | 0.583 | 0.6466 | 3.216M |
| Mar 26, 2024 | 0.60 | 0.61 | 0.5801 | 0.6099 | 522386.0 |
| Mar 25, 2024 | 0.5701 | 0.6151 | 0.5701 | 0.6092 | 578807.0 |
| Mar 22, 2024 | 0.565 | 0.591 | 0.55 | 0.56 | 434211.0 |
| Mar 21, 2024 | 0.59 | 0.595 | 0.5622 | 0.5739 | 577367.0 |
| Mar 20, 2024 | 0.60 | 0.6101 | 0.5701 | 0.59 | 654029.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.37
Minimum
Jan 19 2024
23.78
Maximum
Aug 17 2022
5.231
Average
3.46
Median
Jan 02 2020
Price Benchmarks
| EyePoint Pharmaceuticals Inc | 16.16 |
| Regeneron Pharmaceuticals Inc | 890.86 |
| Bio-Path Holdings Inc | 2.63 |
| Aileron Therapeutics Inc | 5.055 |
| Scholar Rock Holding Corp | 13.98 |
Price Related Metrics
| PS Ratio | 6.863 |
| Price to Book Value | 3.447 |
| Earnings Yield | -61.73% |
| Market Cap | 177.85M |